메뉴 건너뛰기
Nature Clinical Practice Neurology
Volumn 3, Issue 11, 2007, Pages 600-601
Clinical assessment of progressive supranuclear palsy over time: New rating scale validated: Commentary
Author keywords

[No Author keywords available]
Indexed keywords

BASAL GANGLION; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; DISEASE COURSE; GLOBUS PALLIDUS; HUMAN; INTERRATER RELIABILITY; NEUROPATHOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROGRESSIVE SUPRANUCLEAR PALSY RATING SCALE; QUALITY OF LIFE; RATING SCALE; SHORT SURVEY; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; SURVIVAL RATE; VALIDITY;
EID: 35748971485     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0603     Document Type: Short Survey
Times cited : (5)
References (5)
  • 1
    • 0034956738 scopus 로고    scopus 로고
    • The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK
    • Nath U et al. (2001) The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 124: 1438-1449
    • (2001) Brain , vol.124 , pp. 1438-1449
    • Nath, U.1
  • 2
    • 0042512366 scopus 로고    scopus 로고
    • Progressive supranuclear palsy: Where are we now?
    • Burn DJ and Lees AJ (2002) Progressive supranuclear palsy: Where are we now? Lancet Neurol 1: 359-369
    • (2002) Lancet Neurol , vol.1 , pp. 359-369
    • Burn, D.J.1    Lees, A.J.2
  • 3
    • 33845699846 scopus 로고    scopus 로고
    • An update on pharmacological approaches to neurodegenerative diseases
    • Scatena R et al. (2007) An update on pharmacological approaches to neurodegenerative diseases. Expert Opin Investig Drugs 16: 59-72
    • (2007) Expert Opin Investig Drugs , vol.16 , pp. 59-72
    • Scatena, R.1
  • 4
    • 20444436764 scopus 로고    scopus 로고
    • Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism
    • Williams DR et al. (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 128: 1247-1258
    • (2005) Brain , vol.128 , pp. 1247-1258
    • Williams, D.R.1
  • 5
    • 33746860796 scopus 로고    scopus 로고
    • Measuring quality of life in PSP: The PSP-QoL
    • Schrag A et al. (2006) Measuring quality of life in PSP: The PSP-QoL. Neurology 67: 39-44
    • (2006) Neurology , vol.67 , pp. 39-44
    • Schrag, A.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.